{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:06:04Z","timestamp":1789373164366,"version":"build-2803163510"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.msard.2026.107416","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:03:50Z","timestamp":1785283430000},"page":"107416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A high price to pay: Preserving choice for people with multiple sclerosis"],"prefix":"10.1016","volume":"114","author":[{"given":"Jeannette","family":"Lechner-Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Agland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107416_bib0002","unstructured":"Australian Government Department of Health, Disability and Ageing. Pharmaceutical Benefits Scheme (PBS). Available from: https:\/\/www.pbs.gov.au\/about. Accessed July 13, 2026."},{"key":"10.1016\/j.msard.2026.107416_bib0006","unstructured":"Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA). Benefit assessment of medicinal products according to Section 35a SGB V (AMNOG). Berlin: G-BA. Available from: https:\/\/www.g-ba.de\/english\/benefitassessment\/. Accessed July 13, 2026."},{"key":"10.1016\/j.msard.2026.107416_bib0009","series-title":"Pricing of medicines in Switzerland: Frequently asked questions","year":"2025"},{"key":"10.1016\/j.msard.2026.107416_bib0001","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s40263-022-00965-7","article-title":"High-efficacy therapies for treatment-na\u00efve individuals with relapsing-remitting multiple sclerosis","volume":"36","author":"Freeman","year":"2022","journal-title":"CNS Drugs."},{"issue":"8","key":"10.1016\/j.msard.2026.107416_bib0007","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jval.2014.08.2673","article-title":"Evolution of drug reimbursement in Canada: the pan-Canadian Pharmaceutical Alliance for new drugs","volume":"17","author":"Husereau","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.msard.2026.107416_bib0003","series-title":"A comparison of international pharmaceutical reimbursement systems","year":"2020"},{"key":"10.1016\/j.msard.2026.107416_bib0005","series-title":"NICE technology appraisal and highly specialised technologies guidance: the manual","year":"2022"},{"key":"10.1016\/j.msard.2026.107416_bib0008","series-title":"Operating Policies and Procedures Manual","year":"2026"},{"key":"10.1016\/j.msard.2026.107416_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13561-025-00705-9","article-title":"Overview of the Japanese Rapid Introduction Premium as a drug pricing framework to enhance patient access to innovative drugs","volume":"16","author":"Takamura","year":"2026","journal-title":"Health Econ Rev."},{"key":"10.1016\/j.msard.2026.107416_bib0004","unstructured":"United States Congress. Inflation Reduction Act of 2022. Public Law No. 117-169, 136 Stat. 1818 (2022)."},{"issue":"9","key":"10.1016\/j.msard.2026.107416_bib0011","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated research and development investment needed to bring a new medicine to market, 2009-2018","volume":"323","author":"Wouters","year":"2020","journal-title":"JAMA."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826004517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826004517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:04:51Z","timestamp":1789369491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826004517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":11,"alternative-id":["S2211034826004517"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107416","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A high price to pay: Preserving choice for people with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107416"}}